ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 123 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2022. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $184,933 | -4.5% | 91,100 | +8.2% | 0.00% | – |
| Q2 2023 | $193,591 | +11.5% | 84,170 | +46.9% | 0.00% | – |
| Q1 2023 | $173,619 | +51.8% | 57,300 | +16.7% | 0.00% | – |
| Q4 2022 | $114,403 | +87.5% | 49,100 | +54.4% | 0.00% | – |
| Q3 2022 | $61,000 | -7.6% | 31,800 | +31.4% | 0.00% | – |
| Q2 2022 | $66,000 | +57.1% | 24,200 | +71.6% | 0.00% | – |
| Q1 2022 | $42,000 | -23.6% | 14,100 | 0.0% | 0.00% | – |
| Q4 2021 | $55,000 | -8.3% | 14,100 | 0.0% | 0.00% | – |
| Q3 2021 | $60,000 | +39.5% | 14,100 | 0.0% | 0.00% | – |
| Q2 2021 | $43,000 | -84.8% | 14,100 | -52.7% | 0.00% | – |
| Q3 2018 | $282,000 | – | 29,821 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,705,128 | $10,300,000 | 4.44% |
| RTW INVESTMENTS, LP | 5,666,754 | $15,754,000 | 0.59% |
| COWEN AND COMPANY, LLC | 926,200 | $2,575,000 | 0.22% |
| Hudson Bay Capital Management LP | 850,000 | $2,363,000 | 0.05% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,774,915 | $4,934,000 | 0.03% |
| Point72 Asset Management, L.P. | 1,897,284 | $5,274,000 | 0.03% |
| 683 Capital Management, LLC | 77,368 | $215,000 | 0.02% |
| Secure Asset Management, LLC | 10,000 | $28,000 | 0.02% |
| Qube Research & Technologies Ltd | 166,138 | $462,000 | 0.01% |
| Verition Fund Management LLC | 174,455 | $485,000 | 0.01% |